BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38112714)

  • 1. SARS-CoV-2 Omicron variants BA.4 and BA.5 dominated the fifth COVID-19 epidemiological wave in Mexico.
    Taboada BI; Zárate S; García-López R; Muñoz-Medina JE; Gómez-Gil B; Herrera-Estrella A; Sanchez-Flores A; Salas-Lais AG; Roche B; Martínez-Morales G; Domínguez Zárate H; Duque Molina C; Avilés Hernández R; López S; Arias CF
    Microb Genom; 2023 Dec; 9(12):. PubMed ID: 38112714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omicron-BA.1 Dispersion Rates in Mexico Varied According to the Regional Epidemic Patterns and the Diversity of Local Delta Subvariants.
    Zárate S; Taboada B; Rosales-Rivera M; García-López R; Muñoz-Medina JE; Sanchez-Flores A; Herrera-Estrella A; Gómez-Gil B; Selem Mojica N; Salas-Lais AG; Vazquez-Perez JA; Cabrera-Gaytán DA; Fernandes-Matano L; Uribe-Noguez LA; Chale-Dzul JB; Maldonado Meza BI; Mejía-Nepomuceno F; Pérez-Padilla R; Gutiérrez-Ríos RM; Loza A; Roche B; López S; Arias CF
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the Dynamics of Omicron (BA.1, BA.2, and BA.5) Waves and Emergence of the Deltacton Variant: Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus (Oct 2021-Oct 2022).
    Chrysostomou AC; Vrancken B; Haralambous C; Alexandrou M; Gregoriou I; Ioannides M; Ioannou C; Kalakouta O; Karagiannis C; Marcou M; Masia C; Mendris M; Papastergiou P; Patsalis PC; Pieridou D; Shammas C; Stylianou DC; Zinieri B; Lemey P; The Comessar Network ; Kostrikis LG
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 BW lineage, a fast-growing Omicron variant from southeast Mexico bearing relevant escape mutations.
    García-López R; Rivera-Gutiérrez X; Rosales-Rivera M; Zárate S; Muñoz-Medina JE; Roche B; Herrera-Estrella A; Gómez-Gil B; Sanchez-Flores A; Taboada B; Arias CF
    Infection; 2023 Oct; 51(5):1549-1555. PubMed ID: 37058241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominance of Three Sublineages of the SARS-CoV-2 Delta Variant in Mexico.
    Taboada B; Zárate S; García-López R; Muñoz-Medina JE; Sanchez-Flores A; Herrera-Estrella A; Boukadida C; Gómez-Gil B; Selem Mojica N; Rosales-Rivera M; Salas-Lais AG; Gutiérrez-Ríos RM; Loza A; Rivera-Gutierrez X; Vazquez-Perez JA; Matías-Florentino M; Pérez-García M; Ávila-Ríos S; Hurtado JM; Herrera-Nájera CI; Núñez-Contreras JJ; Sarquiz-Martínez B; García-Arias VE; Santiago-Mauricio MG; Martínez-Miguel B; Enciso-Ibarra J; Cháidez-Quiróz C; Iša P; Wong-Chew RM; Jiménez-Corona ME; López S; Arias CF
    Viruses; 2022 May; 14(6):. PubMed ID: 35746637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates of SARS-CoV-2 Omicron BA.2 Subvariant Severity in New England.
    Strasser ZH; Greifer N; Hadavand A; Murphy SN; Estiri H
    JAMA Netw Open; 2022 Oct; 5(10):e2238354. PubMed ID: 36282501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5.
    Torres C; Nabaes Jodar M; Acuña D; Montaño RMZ; Culasso ACA; Amadio AF; Aulicino P; Ceballos S; Cacciabue M; Debat H; Dus Santos MJ; Eberhardt MF; Espul C; Fay F; Fernández MA; Fernández F; Muñoz JMF; Ferrini F; Gallego F; Giri AA; Cerri A; Bolatti E; Gismondi MI; Goya S; Gramundi I; Irazoqui JM; König GA; Leiva V; Lucero H; Marquez N; Nardi C; Ortiz B; Pianciola L; Pintos CB; Puebla AF; Rastellini CV; Rojas AE; Sfalcin J; Suárez A; Tittarelli E; Toro R; Villanova GV; Ziehm MC; Zimmermann MC; Zunino S; Proyecto Pais Working Group ; Valinotto L; Viegas M
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of novel SARS-CoV-2 rapid antigen tests in the era of omicron outbreak.
    Widyasari K; Kim S
    PLoS One; 2023; 18(8):e0289990. PubMed ID: 37561721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omicron (B.1.1.529) variant and its subvariants and lineages may lead to another COVID-19 wave in the world? -An overview of current evidence and counteracting strategies.
    Sah R; Rais MA; Mohanty A; Chopra H; Chandran D; Bin Emran T; Dhama K
    Int J Surg Open; 2023 Jun; 55():100625. PubMed ID: 37255735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Diversity of SARS-CoV-2 Omicron Variant in South American Countries.
    Luna N; Muñoz M; Ramírez AL; Patiño LH; Castañeda SA; Ballesteros N; Ramírez JD
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Genomic, Epidemiological, and Clinical Description of the SARS-CoV-2 Omicron Variant in Mexico City.
    Cedro-Tanda A; Gómez-Romero L; de Anda-Jauregui G; Garnica-López D; Alfaro-Mora Y; Sánchez-Xochipa S; García-García EF; Mendoza-Vargas A; Frías-Jiménez EJ; Moreno B; Campos-Romero A; Moreno-Camacho JL; Alcantar-Fernández J; Ortíz-Ramírez J; Benitez-González M; Trejo-González R; Aguirre-Chavarría D; Núñez-Martínez ME; Uribe-Figueroa L; Angulo O; Ruiz R; Hidalgo-Miranda A; Herrera LA
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical severity of Omicron subvariants BA.1, BA.2, and BA.5 in a population-based cohort study in British Columbia, Canada.
    Russell SL; Klaver BRA; Harrigan SP; Kamelian K; Tyson J; Hoang L; Taylor M; Sander B; Mishra S; Prystajecky N; Janjua NZ; Zlosnik JEA; Sbihi H
    J Med Virol; 2023 Jan; 95(1):e28423. PubMed ID: 36546412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020-2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality.
    Kandeel A; Moatasim Y; Fahim M; Bahaaeldin H; El-Shesheny R; Roshdy WH; Kamel MN; Shawky S; Gomaa M; Naguib A; Guindy NE; Deghedy O; Kamel R; Khalifa M; Galal R; Hassany M; Mahmoud G; Kandeil A; Afifi S; Mohsen A; Fattah MA; Kayali G; Ali MA; Abdelghaffar K
    BMC Infect Dis; 2023 Aug; 23(1):542. PubMed ID: 37596534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants.
    Qu P; Evans JP; Kurhade C; Zeng C; Zheng YM; Xu K; Shi PY; Xie X; Liu SL
    mBio; 2023 Feb; 14(1):e0317622. PubMed ID: 36625591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Surveillance of SARS-CoV-2 in the Southern Province of Zambia: Detection and Characterization of Alpha, Beta, Delta, and Omicron Variants of Concern.
    Katowa B; Kalonda A; Mubemba B; Matoba J; Shempela DM; Sikalima J; Kabungo B; Changula K; Chitanga S; Kasonde M; Kapona O; Kapata N; Musonda K; Monze M; Tembo J; Bates M; Zumla A; Sutcliffe CG; Kajihara M; Yamagishi J; Takada A; Sawa H; Chilengi R; Mukonka V; Muleya W; Simulundu E
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2.
    Qu P; Evans JP; Faraone JN; Zheng YM; Carlin C; Anghelina M; Stevens P; Fernandez S; Jones D; Lozanski G; Panchal A; Saif LJ; Oltz EM; Xu K; Gumina RJ; Liu SL
    Cell Host Microbe; 2023 Jan; 31(1):9-17.e3. PubMed ID: 36476380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerating pandemic response with the emergency Omicron RT-PCR test: A comprehensive solution for COVID-19 diagnosis and tracking.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Chen CS; Tang SH; Perng CL; Chang FY; Wang CH; Hung YJ; Shang HS
    J Med Virol; 2023 Jul; 95(7):e28914. PubMed ID: 37394776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. As the SARS-CoV-2 virus evolves, should Omicron subvariant BA.2 be subjected to quarantine, or should we learn to live with it?
    Xu R; Wang W; Zhang W
    Front Public Health; 2022; 10():1039123. PubMed ID: 36504951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.
    Smith MF; Holland SC; Lee MB; Hu JC; Pham NC; Sullins RA; Holland LA; Mu T; Thomas AW; Fitch R; Driver EM; Halden RU; Villegas-Gold M; Sanders S; Krauss JL; Nordstrom L; Mulrow M; White M; Murugan V; Lim ES
    mBio; 2023 Feb; 14(1):e0310122. PubMed ID: 36622143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omicron variant evolution on vaccines and monoclonal antibodies.
    Sabbatucci M; Vitiello A; Clemente S; Zovi A; Boccellino M; Ferrara F; Cimmino C; Langella R; Ponzo A; Stefanelli P; Rezza G
    Inflammopharmacology; 2023 Aug; 31(4):1779-1788. PubMed ID: 37204696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.